1. Figure 2 Aβ-PET scans obtained using different tracers
Figure 2 | Aβ-PET scans obtained using different tracers. Surface projection images from five patients with Alzheimer disease (AD), obtained with different amyloid-β (Aβ)-PET radiotracers: 11C-Pittsburgh compound B (PiB), 18F-florbetapir, 18F-florbetaben, 18F-flutemetamol and 18F-NAV4694. Images show typical patterns of tracer retention associated with AD, with the highest retention in the frontal, temporal and posterior cingulate cortices reflecting the location of Aβ deposits in the brain. Three of these Aβ-PET tracers, florbetapir, flutemetamol and florbetaben, are approved for clinical use by the FDA and European Medicines Agency. Images generated through CapAIBL ( Commonwealth Scientific and Industrial Research Organisation (CSIRO) Biomedical Imaging Group. SUVR, standardized uptake value ratio.
Villemagne, V. L. et al. (2018) Imaging tau and amyloid‑β proteinopathies in Alzheimer disease and other conditions
Nat. Rev. Neurol. doi: /nrneurol